Vaxart Completes Dosing of the Lead-In Cohort in Bivalent Norovirus Vaccine Phase 1b Clinical Trial - Associated Press
Vaxart Completes Dosing of the Lead-In Cohort in Bivalent Norovirus Vaccine Phase 1b Clinical Trial Associated Press This *content* is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.